Plenary Sessions
at The MedTech Conference

AdvaMed_101916-34.jpgKeynote speakers will take the plenary stage for six sessions throughout The MedTech Conference, highlighting the future of medical technology, impact on patients and beyond. Be sure to include these can’t-miss sessions in your schedule on Tuesday and Wednesday!

Scroll to view all of our plenary sessions, or click the session you want to learn more about below:


 

Tuesday Breakfast

Tuesday, September 26 | 7:30 am – 9:00 am
Convention Center – Room 220

Partners for Innovation in Health Care

Ian Burkhart

Six years ago, Ian Burkhart dove into a wave at the beach and sustained a spinal cord injury rendering him a quadriplegic. Since then he has participated in a neural bridging research study by having an implant in his brain in a clinical trial, Reanimation in Tetraplegia, through The Ohio State University Wexner Medical Center and the Battelle Memorial Institute, which has restored some movement in his right hand. Hear his amazing and inspiring story first hand.

Ian has created the Ian Burkhart Foundation, which is dedicated to restoring lives and providing hope to individuals with spinal cord injuries.



Scott Gottlieb, M.D., Commissioner of Food and Drugs, FDA

Dr. Scott Gottlieb was recently sworn in as the 23rd Commissioner of Food and Drugs and for most of us this will be our rst opportunity to hear from him in person since taking his new role at the FDA. Dr. Gottlieb is a physician, medical policy expert, and public health advocate who previously served as the FDA’s Deputy Commissioner for Medical and Scientific Affairs and before that, as a senior advisor to the FDA Commissioner.

He also worked on implementation of the Medicare drug benefit as a senior advisor to the Administrator of the Centers for Medicare and Medicaid Services, where he supported policy work on quality improvement and the agency’s coverage process, particularly as it related to new medical technologies.

Dr. Gottlieb will deliver remarks about the state of the FDA and how it interfaces with the industry and then be joined by AdvaMed’s President & CEO, Scott Whitaker, for an in–depth interview.


Tuesday Lunch

Tuesday, September 26 | 12:30 pm – 2:00 pm
Convention Center – Room 220

In classic tech rapid–fire format, this moderated session is designed to give you a glimpse of what
the future holds for generations to come. Now that AdvaMed’s President & CEO has been with the organization for an entire year, you won’t want to miss his 2017 State of the Industry address. Anchoring this plenary session is a dynamic and world recognized patient who will join conference chairman and Varian Medical Systems CEO, Dow R. Wilson, for an intimate discussion of how medtech, patients and physicians interface in today’s socially awakened world.



State of the Industry

Scott Whitaker, President & Chief Executive Officer, AdvaMed



Moderator: Deborah Kilpatrick, Ph.D., Chief Executive Officer, Evidation Health

 

 

Devices are Consumer Engagement’s Future

Perhaps the most prominent disease in the health care industry is poor consumer engagement. Poor compliance and follow up, often below 10% of people, is perhaps the biggest drag on nearly every drug, therapy, medical procedure and preventative activity. Large clinical data sets and AI techniques are providing the ability to phenotype people and determine who are likely responders and who aren’t. But, to do this, detailed streaming data and tools that follow people through their lives are essential. Medical devices are perhaps the best the chassis of the next generation of data–generation and consumer engagement tools in the health care industry.

David J. Brailer, MD, PhD, CEO, Health Evolution Partners

 

 

Silicon Valley’s Growing Contribution to Health Care

Joshua Newman, MD, MSHS, Chief Medical Officer, Salesforce



Patient Perspective

Dow R. Wilson, President and Chief Executive Officer, Varian Medical Systems



Leslie Botnick, MD

 



Shannen DohertyActress, producer, author, and television director 


Tuesday Afternoon

Tuesday, September 26 | 4:00 pm – 5:30 pm
Convention Center – Room 220



Innovation as a Discipline

With her background in leading innovative organizations (including Facebook, Google, Motorola Mobility and DARPA) to develop breakthrough products that shape the world we live in, Regina E. Dugan’s insights are especially relevant as the medtech industry focuses on the intersection of innovative technologies and health care for the future.

Keynote Speaker: Dr. Regina Dugan, Vice President of Engineering, Building 8, Facebook



MedTech Innovator $500K Competition Finals

 

The MedTech Conference is excited to welcome MedTech Innovator back to the plenary stage on the afternoon of Tuesday, September 26. Four finalist companies from the MedTech Innovator competition will present to a panel of industry–leading judges and compete for the audience vote to win $500,000 in prizes and the award of MedTech Innovator 2017!

MedTech Innovator is the industry’s nonprofit global competition and accelerator for medical device, digital health and diagnostic companies. Its mission is to improve the lives of patients by accelerating the growth of companies that are transforming the health care system. In 2017, MedTech Innovator, with the support of its partners and sponsors, will give out $500,000 in cash prizes, scholarships and in–kind awards.

The MedTech Conference and AdvaMed Accel are proud to partner with MedTech Innovator for the third consecutive year.

Host: Paul Grand, CEO, MedTech Innovator


Wednesday Morning

Wednesday, September 27 | 7:30 am – 8:45 am
Convention Center – 210C

CMS Town Hall

We are pleased to announce that we will be holding a CMS Town Hall session at The MedTech Conference, featuring representatives from the Centers for Medicare and Medicaid Services (CMS). Senior CMS leaders will participate in an open Q&A session covering developments pertaining to medical technologies including Medicare coverage, new payment models and patient access to new technologies. 

Speakers:

Demetrios Kouzoukas, CMS Principal Deputy Administrator and Director of the Center for Medicare
Carol Blackford, Director, Hospital & Ambulatory Policy Group
Tamara Syrek Jensen, Director, Coverage and Analysis Group
Amy Bassano, Deputy Director, Center for Medicare and Medicaid Innovation


Wednesday Lunch

Wednesday, September 27 | 12:30 pm – 2:15 pm
Convention Center – Room 220

Lunch with Champions

For the first time, we will recognize a groundbreaking technology that is particularly applicable for tackling global health needs. We’ll also recognize a global leader in medtech with a storied career and tremendous success and, nally, we’ll be joined by four–time Super Bowl Champion and early–stage investor Joe Montana.

Joe Montana, Legendary NFL Quarterback and Medical Technology Investor

Widely considered the best NFL quarterback of all time, Joe Montana personi es performance excellence and personal integrity both on and o the eld. Yet the word most closely associated with him is not winner — it’s leader.

Montana co–founded Liquid 2 Ventures in 2015, a seed stage venture capital rm that has invested in startups like Vivid Vision, a virtual reality technology to treat lazy eye, and other innovative companies focused on deep learning, patient engagement and more.

Montana, recently named a top 15 celebrity investor by CBInsights, will bring his unique perspective on preparation, teamwork and performance under pressure both on and o the eld to The MedTech Conference plenary stage this fall.

 

Global Health Innovator Award

Presented by TEAMFund
In Partnership with MedTech Innovator
Generously supported by

TEAMFund.png 

 

Global Health Innovator Finalists

 

Lifetime Achievement Award presentation to Jack Wareham, sponsored by Piper Jaffray


Wednesday Afternoon

Wednesday, September 27 | 2:30 pm – 4:15 pm Convention Center – 210C

CDRH Town Hall

Join us for an exclusive peek into FDA’s Center for Devices and Radiological Health (CDRH) during our Wednesday afternoon CDRH Town Hall. This is a rare opportunity to interact directly with Dr. Jeffrey Shuren and other senior office leaders from CDRH. After Dr. Shuren provides an update on CDRH priorities, panelists will answer specific questions from the audience. Take advantage of this session and get answers to all of your burning questions directly from CDRH. This exclusive, interactive Town Hall will allow you to engage in relevant dialogue with:

Jeffrey E. Shuren, M.D., J.D., Director, Center for Devices and Radiological Health, FDA
Thomas Gross, M.D., Director, Office of Surveillance and Biometrics, FDA CDRH
William Maisel, M.D., M.P.H., Deputy Center Director for Science and CDRH Chief Scientist, FDA CDRH
Robin Newman, M.S.N., Ed.D., Director, Office of Compliance, FDA CDRH